Patients with NAFLD and NASH exhibit lower levels of serum antioxidants, including the glutathione system and CAT and SOD enzymes, which, in turn, result in higher susceptibility to cellular oxidative damage [251,252,253]. The gene discussed is CAT; the disease is metabolic dysfunction-associated steatotic liver disease.